New diagnostic tools such as RNA epigenetics and chromatin structures have the potential to reduce drug resistance in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) patients.
from Medindia Health News https://ift.tt/2GeJsOw
No comments:
Post a Comment